Maximize SRL
The score of Maximize shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +85 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Maximize's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 28 Apr 2025
- Year ended 31 Dec 2023filed on 15 May 2024
- Year ended 31 Dec 2022filed on 25 May 2023
- Year ended 31 Dec 2021filed on 18 May 2022
Maximize's financial analysis
- Solvency-203.2%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Maximize
Maximize's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0433.126.180
- VAT number
- BE0433126180
- Peppol
- Registered · 0208:0433126180 · as of 01 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Jan 1988
- Registered office
- 2020 Antwerp
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Maximize (SRL) has been based in Antwerp since 1988, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 21,706 € and equity of −40,778 €; its revenue is not published. Its solvency stands at -203.2%, below the median of its sector (46.0%).
Companies similar to Maximize
Companies in the same business, of comparable size and area, outside its group.
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Gyntech Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 20,358 €
- Medicode Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 63,460 €
- Medidat Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 57,897 €
- Globex International Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 92,829 €
- Nature Avenue Wholesale of pharmaceutical and medical goods Lier · balance sheet 105,922 €
- Lopital België Wholesale of pharmaceutical and medical goods Aartselaar · balance sheet 120,231 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
Frequently asked questions about Maximize
What is the revenue of Maximize?
Maximize files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Maximize?
In Belgium, the VAT number is the company number prefixed with BE: BE0433126180 for Maximize, if the company is VAT-registered. Its company number (CBE) is 0433.126.180.
Where is the registered office of Maximize?
According to the CBE register, the registered office of Maximize is in 2020 Antwerp.
What is the equity of Maximize?
At the close of the 2025 financial year, the equity of Maximize amounts to -40,778 €, a solvency of -203.2% of total assets.
Who manages Maximize?
The register lists 1 active mandates at Maximize. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Maximize
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →